Clinical Trials Browser

Carcinoma, Transitional Cell

NCT07291063 2025-12-18

Anti-PD-1/PD-L1 Antibodies Plus Gemcitabine and Cisplatin for Advanced CCA

Recruiting

50 enrolled

Gastrointestinal

Cholangiocarcinoma

NCT07243288 2025-11-21

RADIOPAN

Active not recruiting

400 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06893380 2025-09-15

GENTIS

Recruiting

61 enrolled

Gastrointestinal

Biliary Tract Neoplasms

NCT03724994 2025-08-29

CHAMP

Completed

201 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06975917 2025-05-16

TOG-SAFRADJU

Active not recruiting

600 enrolled

Gastrointestinal

Biliary Tract Neoplasms

NCT06883136 2025-03-19

Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients

Enrolling by invitation

43 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06809374 2025-02-05

Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer

Completed

100 enrolled

Gastrointestinal

Pancreatic Cancer Resectable

NCT04544969 2025-01-28

Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC

Recruiting

50 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Neoplastic Cells, Circulating

NCT04423731 2024-11-20

Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)

Active not recruiting

251 enrolled

Gastrointestinal

Locally Advanced Pancreatic Adenocarcinoma

NCT04115410 2020-05-28

PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

Unknown

4,724 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04133155 2020-03-13

Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer

Completed

103 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT04258163 2020-02-10

Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy

Completed

760 enrolled

Breast

Breast Neoplasms

NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

Unknown

300 enrolled

Breast

Breast Cancer Organoids

NCT03668418 2018-09-12

xenoZ

Unknown

120 enrolled

Gastrointestinal

Biliary Tract Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT00235235 2015-12-09

A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer

Terminated

80 enrolled

Breast

Breast Neoplasms

NCT00419042 2013-10-01

Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)

Completed

100 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT00795678 2013-08-02

Chemotherapeutic Agents in Brain/Breast

Completed

10 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis

NCT00301301 2010-01-12

A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Completed

39 enrolled

Lymphoid

Lymphoma, Non-Hodgkin

Clinical Trials

Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC

Anti-PD-1/PD-L1 Antibodies Plus Gemcitabine and Cisplatin for Advanced CCA

RADIOPAN

GENTIS

CHAMP

TOG-SAFRADJU

Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients

Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer

Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC

Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)

PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer

Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy

Breast Cancer Treatment Based on Organ-like Culture

xenoZ

A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer

Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)

Chemotherapeutic Agents in Brain/Breast

A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)